Senseonics Holdings (SENS): Management Meetings Confirm Hyper Growth Sales Trajectory - Leerink

September 20, 2016 7:34 AM EDT
Get Alerts SENS Hot Sheet
Price: $3.99 +1.79%

Rating Summary:
    5 Buy, 0 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 13 | Down: 12 | New: 15
Trade SENS Now!
Join SI Premium – FREE

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

Leerink Partners analyst, Danielle Antalffy, reiterated her Outperform rating on shares of Senseonics Holdings (NYSE: SENS) and raised her price target to $6.00 from $4.50 after hosting a week of investor meetings with President & CEO Tim Goodnow and CFO Don Elsey.

The analyst stated: "These meetings supported our bullish outlook on SENS and the Eversense implantable CGM (continuous glucose monitor) EU launch now underway and U.S. launch in 2018 and beyond. And they reinforced our view that SENS has a sustainable hyper-growth sales trajectory longer-term, with a number of key milestones in the near-term to continue to support the shares".

For an analyst ratings summary and ratings history on Senseonics Holdings click here. For more ratings news on Senseonics Holdings click here.

Shares of Senseonics Holdings closed at $4.00 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Analyst Comments

Add Your Comment